<DOC>
	<DOC>NCT00060814</DOC>
	<brief_summary>The purpose of this pilot study is to examine the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among methadone maintenance therapy patients.</brief_summary>
	<brief_title>Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients</brief_title>
	<detailed_description>This is a one-arm, open label pilot study of MMT patients to determine whether bupropion, nicotine replacement therapy, and behavioral counseling is a feasible and potentially effective intervention for smoking cessation. The smoking behaviors of participants will be be followed for 6 months post quit-date to determine effect-size estimates for a future, large scale trial.</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<criteria>Patients in longterm methadone maintenance treatment Patient smokes at least 10 cigarettes per day, are stable on their use of methadone (phase 2 or higher treatment), smoked for at least 1 year, be willing to participate for 6 months, and not have used bupropion or nicotine replacement therapy for 6 months Patients who use prescription drug regimens that might affect methadone or bupropion metabolism Patients with cardiovascular disease, asthma, COPD Patients who are pregnant or breastfeeding Patients with regular use of alcohol, other illicit drugs, or other types of tobacco (chewing or pipe for example)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>